Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19–Associated Venous Thromboembolism-Reference-Cited by-同舟云学术

Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19–Associated Venous Thromboembolism

Published:2022-12-01 Issue:12 Volume:182 Page:1326
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Jara-Palomares Luis¹²,Bikdeli Behnood³⁴⁵⁶,Jiménez David⁷⁸⁹,Muriel Alfonso¹⁰¹¹,Martin del Pozo Mar¹²,Demelo-Rodríguez Pablo¹³,Monreal Manuel¹⁴

Affiliation:

1. Medical Surgical Unit of Respiratory Diseases, Virgen del Rocio Hospital and Instituto de Biomedicina, Seville, Spain

2. CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain

3. Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

4. Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

5. Yale New Haven Hospital, Yale Center for Outcomes Research and Evaluation, New Haven, Connecticut

6. Cardiovascular Research Foundation, New York, New York

7. Respiratory Department, Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigacion Sanitaria (IRYCIS), Madrid, Spain

8. Medicine Department, Universidad de Alcalá, Madrid, Spain

9. CIBERES, Madrid, Spain

10. Biostatistics Department, Ramón y Cajal Hospital, IRYCIS, CIBERES, Madrid, Spain

11. University of Alcala, Madrid, Spain

12. Department of Internal Medicine, Hospital Universitario Infanta Sofía, Madrid, Spain

13. Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain

14. Faculty of Health Sciences, Universidad Católica San Antonio de Murcia, Murcia, Spain

Abstract

This cohort study assesses the rate of recurrence of venous thromboembolism (VTE) in patients with COVID-19–associated VTE who discontinued anticoagulation therapy.

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2797777/jamainternal_jarapalomares_2022_ld_220038_1670009042.10942.pdf

Reference6 articles.

1. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST Guideline and Expert Panel Report.;Moores;Chest,2020

2. Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.;Spyropoulos;J Thromb Haemost,2020

3. Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report.;Stevens;Chest,2021

4. Rationale, design and methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE).;Bikdeli;Thromb Haemost,2018

5. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.;Iorio;Arch Intern Med,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study;eClinicalMedicine;2024-07

2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding;Research and Practice in Thrombosis and Haemostasis;2023-10

3. Management and Prevention of Venous Thromboembolism in Patients with COVID-19;Current Treatment Options in Cardiovascular Medicine;2023-08-25

4. COVID-19-assoziierte venöse Thrombembolie;Phlebologie;2023-08

5. COVID-19-assoziierte venöse Thrombembolie;Gefäßmedizin Scan - Zeitschrift für Angiologie, Gefäßchirurgie, diagnostische und interventionelle Radiologie;2023-06